A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

The search for long COVID treatments continues, as a randomized clinical trial found that a two-week course of metformin or ursodeoxycholic acid (UDCA) did not meaningfully improve recovery from ...

A new study reveals that the world’s most widely used diabetes drug works through a previously unknown brain pathway ...

Weight-loss jabs could prevent and treat addiction to alcohol, cigarettes and drugs, according to a large study. Experts ...

The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use ...

GLP-1 drugs tied to lower addiction risk reduce substance use disorders and related harms in veterans with Type 2 diabetes, ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

Stroke is a leading cause of death and disability worldwide, with staggering statistics that demand urgent attention. Every year, approximately 12.2 million new strokes are diagnosed globally, and one ...

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

A large study of US veterans suggests that diabetes and weight-loss medicines may curb cravings and lower severe addiction outcomes, though clinical trials are still needed.

Credit: Getty Images Our easy-to-read fact sheets provide patients with an overview for type 2 diabetes medications that also induce weight loss. Our easy-to-read fact sheets provide clinicians with ...